SNORD89
gene geneOn this page
Also known as HBII-289
Summary
SNORD89 (small nucleolar RNA, C/D box 89, HGNC:32750) is a small nucleolar RNA gene on chromosome 2q11.2.
Predicted to be involved in RNA processing. Predicted to be located in nucleolus.
Source: NCBI Gene 692205 — RefSeq curated summary.
At a glance
- Gene type: non-coding (snoRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32750 |
| Approved symbol | SNORD89 |
| Name | small nucleolar RNA, C/D box 89 |
| Location | 2q11.2 |
| Locus type | RNA, small nucleolar |
| Status | Approved |
| Aliases | HBII-289 |
| Ensembl gene | ENSG00000212283 |
| Ensembl biotype | snoRNA |
| Entrez | 692205 |
| RNAcentral | URS0000633321 — snoRNA, 114 nt, 5 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 snoRNA
ENST00000390981
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000390981 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001508765 | 101272936 | 101273049 |
Expression profiles
Bgee: expression breadth ubiquitous, 229 present calls, max score 99.85.
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 99.85 | gold quality |
| granulocyte | CL:0000094 | 97.51 | gold quality |
| adrenal tissue | UBERON:0018303 | 96.85 | gold quality |
| monocyte | CL:0000576 | 96.11 | gold quality |
| leukocyte | CL:0000738 | 95.96 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.77 | gold quality |
| right lung | UBERON:0002167 | 94.95 | gold quality |
| blood | UBERON:0000178 | 94.64 | gold quality |
| spleen | UBERON:0002106 | 94.57 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 93.53 | gold quality |
| upper lobe of lung | UBERON:0008948 | 92.68 | gold quality |
| endocervix | UBERON:0000458 | 92.58 | gold quality |
| ectocervix | UBERON:0012249 | 92.42 | gold quality |
| left uterine tube | UBERON:0001303 | 92.20 | gold quality |
| omental fat pad | UBERON:0010414 | 92.16 | gold quality |
| peritoneum | UBERON:0002358 | 92.11 | gold quality |
| left ovary | UBERON:0002119 | 92.10 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.03 | gold quality |
| esophagus mucosa | UBERON:0002469 | 91.87 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 91.14 | gold quality |
| tibial nerve | UBERON:0001323 | 91.08 | gold quality |
| right ovary | UBERON:0002118 | 90.97 | gold quality |
| uterine cervix | UBERON:0000002 | 90.37 | gold quality |
| skin of abdomen | UBERON:0001416 | 90.35 | gold quality |
| minor salivary gland | UBERON:0001830 | 90.21 | gold quality |
| lung | UBERON:0002048 | 89.94 | gold quality |
| right lobe of liver | UBERON:0001114 | 89.91 | gold quality |
| right coronary artery | UBERON:0001625 | 89.82 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 89.73 | gold quality |
| body of pancreas | UBERON:0001150 | 89.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.12 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- SNORD89 can be a novel prognostic biomarker and therapeutic target for ovarian cancer. (PMID:31395064)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Snord89 | ENSMUSG00000077704 |
| rattus_norvegicus | Snord89 | ENSRNOG00000055019 |
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.